George T Budd

5PUBLICATIONS
55CO-AUTHORS
Solid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 27, 2025
A Chemotherapy Responsive Ewing Sarcoma Case Report With a Rare FUS::FLI1 Fusion.

Ismail M Elbaz Younes, G Thomas Budd, Yu-Wei Cheng

|Jun 23, 2025
Adjunctive statistical standardization of quantitated adjuvant HER2 and ultra-low HER2 in Canadian Cancer Trials Group MA.27 trial of exemestane versus anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|Jun 02, 2024
Adjunctive Statistical Standardization of Adjuvant Estrogen Receptor and Progesterone Receptor in Canadian Cancer Trials Group MA.27 Postmenopausal Breast Cancer Trial of Exemestane Versus Anastrozole.

Judith-Anne W Chapman, Jane Bayani, Sandip SenGupta

|Oct 26, 2023
Phase II Clinical Trial of Pembrolizumab and Chemotherapy Reveals Distinct Transcriptomic Profiles by Radiologic Response in Metastatic Triple-Negative Breast Cancer.

Avia D Wilkerson, Prerana Bangalore Parthasarathy, Nickolas Stabellini

|Aug 06, 2021
E2112: Randomized Phase III Trial of Endocrine Therapy Plus Entinostat or Placebo in Hormone Receptor-Positive Advanced Breast Cancer. A Trial of the ECOG-ACRIN Cancer Research Group.

Roisin M Connolly, Fengmin Zhao, Kathy D Miller

Pageof 1

Frequent Collaborators

2 joint publications

Matthew J Ellis

2 joint publications

Lois E Shepherd

2 joint publications

Vered Stearns

2 joint publications

George W Sledge